Paclitaxel
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Paclitaxel |
| DrugBank ID | DB01229 |
| KG Predictions | 370 |
| DL Predictions (≥0.7) | 678 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 370 knowledge graph predictions and 678 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| ovarian clear cell adenocarcinoma | KG |
| peritoneum cancer | KG |
| hereditary breast ovarian cancer syndrome | KG |
| primary non-gestational choriocarcinoma of ovary | KG |
| ovarian carcinosarcoma | KG |
| breast carcinoma | KG |
| primary peritoneal carcinoma (disease) | KG |
| malignant Sertoli-Leydig cell tumor of ovary | KG |
| non-small cell lung carcinoma (disease) | KG |
| breast neoplasm | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB01229
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.